Please assess the completion status of the following clinical trial:

Trial Title: Nitric Oxide During Bypass for Arterial Switch Operation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria;~Each participant must meet all of the following criteria to be enrolled in this study:~* Infant aged greater than or equal to 36 weeks gestation~* Infants less than 2 years~* Diagnosed with TGA and requiring Arterial Switch Operation~* Consent of parents/guardian.~Exclusion criteria~Potential participants will be excluded if they meet any of the following criteria:~* They have multiple major congenital anomalies (anomalies which affect the infant's life expectancy or health status)~* They have multiple other cardiac abnormalities (with the exception of ASD, VSD or PDA)~* They weigh less than 2.2kgs.~* Prior surgical exposure to cardio-pulmonary bypass

- Gender: ALL
- Minimum Age: 0 Days
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention arm (Type: ACTIVE_COMPARATOR): • Intervention arm will receive nitric oxide 20 parts per million (ppm) into the oxygenator of a cardio-pulmonary bypass circuit
- Control arm (Type: NO_INTERVENTION): Control arm will not receive nitric oxide, they will receive standard bypass as per local policy

Based on this trial design, predict the completion outcome and termination type (if applicable).